Abstract
CD30, a member of the tumor necrosis factor receptor superfamily, is expressed preferentially by effector or memory helper T cells. Here we show that experimental autoimmune encephalomyelitis (EAE) is ameliorated with markedly reduced induction of antigen-specific Th1 and Th17 cells in CD30 knockout mice. Passive EAE indicated that CD30 on non-hematopoietic parenchymal cell is not required and mixed bone marrow chimera experiments revealed that CD30 signaling on CD4 T cells amplified the development of antigen-specific and encephalitogenic CD4 T cells. Thus, CD30 expression on CD4 T cells is critically involved in the pathogenesis of central nervous system autoimmunity.
Keywords:
CD30; CD30 ligand; Experimental autoimmune encephalomyelitis; Multiple sclerosis.
Copyright © 2015 Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
CD4-Positive T-Lymphocytes / drug effects
-
CD4-Positive T-Lymphocytes / metabolism*
-
Cytokines / metabolism
-
Disease Models, Animal
-
Dose-Response Relationship, Drug
-
Encephalomyelitis, Autoimmune, Experimental / chemically induced
-
Encephalomyelitis, Autoimmune, Experimental / immunology
-
Encephalomyelitis, Autoimmune, Experimental / pathology*
-
Flow Cytometry
-
Ki-1 Antigen / deficiency*
-
Ki-1 Antigen / genetics
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Myelin-Oligodendrocyte Glycoprotein
-
Peptide Fragments
-
Spinal Cord / pathology*
-
Th1 Cells / immunology
-
Th17 Cells / immunology
-
Thymidine / metabolism
-
Time Factors
-
Tritium / metabolism
Substances
-
Cytokines
-
Ki-1 Antigen
-
Myelin-Oligodendrocyte Glycoprotein
-
Peptide Fragments
-
myelin oligodendrocyte glycoprotein (35-55)
-
Tritium
-
Thymidine